Found: 13
Select item for more details and to access through your institution.
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202215811
- By:
- Publication type:
- Article
Patient‐derived organoids, creating a new window of opportunities for pancreatic cancer patients.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202215707
- By:
- Publication type:
- Article
Seasonality of influenza and other respiratory viruses.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202115352
- By:
- Publication type:
- Article
Intercepting IRE1 kinase‐FMRP signaling prevents atherosclerosis progression.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202115344
- By:
- Publication type:
- Article
A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202115298
- By:
- Publication type:
- Article
CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202114990
- By:
- Publication type:
- Article
Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systems.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202114876
- By:
- Publication type:
- Article
Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202114841
- By:
- Publication type:
- Article
Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202114817
- By:
- Publication type:
- Article
Ketone body oxidation increases cardiac endothelial cell proliferation.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202114753
- By:
- Publication type:
- Article
In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202114608
- By:
- Publication type:
- Article
Autologous, lentivirus‐modified, T‐rapa cell "micropharmacies" for lysosomal storage disorders.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202114297
- By:
- Publication type:
- Article
AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.201809824
- By:
- Publication type:
- Article